HR 1718
97th Congress
House
Health
Drug safety and regulation
Drugs and narcotics
Joint diseases
Pharmaceutical research
Research and development
A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of Arthritis, Metabolism, and Digestive Diseases.
Introduced: February 5, 1981
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 9, 1981
Referred to Subcommittee on Health and the Environment.
Feb 5, 1981
Referred to House Committee on Energy and Commerce.
Feb 5, 1981
Introduced in House
Plain-English summary
Directs the Secretary of Health and Human Services, acting through the National Institute of Arthritis, Metabolism, and Digestive Diseases, to: (1) conduct a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis; and (2) report to Congress within one year of enactment of this Act.
What's happening now
Referred to Subcommittee on Health and the Environment.
Committees of jurisdiction
2
Cosponsors
1